Biovian signs an agreement about early-stage development and manufacturing of a COVID-19 vaccine candidate. 15.6.2020 Biovian has signed an agreement with a European biopharmaceutical company for contract development and manufacturing of a COVID-19 vaccine.
Biovian in Biopharma Dealmakers’ latest edition 1.6.2020 Biovian, a Nordic Bio-CDMO is presented in the Biopharma Dealmakers’ June edition that focuses on next-generation therapeutics. The article describes Biovian’s concept of a true One-Stop-Shop that covers both the supply chain and the value chain.
Biovian is looking forward to discussing joint efforts against COVID-19. 30.4.2020 Biovian is looking forward to discussing joint efforts against COVID-19.
Biovian – in the freshly released European Biotechnology Spring issue 2020 16.4.2020 European Biotechnology has published their spring issue with a bioprocessing special. Biovian is one of the CDMOs presented with an editorial article.
Biovian’s new facility for Viral Vector GMP manufacturing is completed 31.3.2020 Biovian has expanded its GMP Viral Vector contract development and manufacturing facilities.
